Einleitung

Aus Hl7wiki
(Teildokument von Pathologiebefund)
Wechseln zu: Navigation, Suche
(Introduction to this Supplement)
(Foreword)
Zeile 8: Zeile 8:
 
into the volumes of the Technical Frameworks.
 
into the volumes of the Technical Frameworks.
  
This supplement is published on September 18, 2017 for
+
This supplement is published on September 27, 2017 for
 
Public Comment. Comments are invited and may be submitted at http://www.ihe.net/Pathology_and_Laboratory_Medicine_(PaLM)/Pathology_and_Laboratory_Medicine_(PaLM)comments.cfm.
 
Public Comment. Comments are invited and may be submitted at http://www.ihe.net/Pathology_and_Laboratory_Medicine_(PaLM)/Pathology_and_Laboratory_Medicine_(PaLM)comments.cfm.
 
In order to be considered in development of the Trial Implementation version of
 
In order to be considered in development of the Trial Implementation version of
the supplement, comments must be received by October 23, 2017.  
+
the supplement, comments must be received by October 27, 2017.  
  
 
This supplement describes changes to the
 
This supplement describes changes to the

Version vom 22. September 2017, 14:04 Uhr

Dieses Material ist Teil des Leitfadens Pathologiebefund.
  • Direkt im Wiki geändert werden sollten Schreibfehler, ergänzende Hinweise.
  • Offene Fragen, die der Diskussionen bedürfen, sollten auf der Diskussionsseite aufgenommen werden.
  • Liste der Seiten dieses Leitfadens: hier, Liste der Seiten, in denen dieses Material verwendet (transkludiert) siehe hier .

Foreword

This is a supplement to the IHE Pathology and Laboratory Medicine Technical Framework V8.0. Each supplement undergoes a process of public comment and trial implementation before being incorporated into the volumes of the Technical Frameworks.

This supplement is published on September 27, 2017 for Public Comment. Comments are invited and may be submitted at http://www.ihe.net/Pathology_and_Laboratory_Medicine_(PaLM)/Pathology_and_Laboratory_Medicine_(PaLM)comments.cfm. In order to be considered in development of the Trial Implementation version of the supplement, comments must be received by October 27, 2017.

This supplement describes changes to the existing technical framework documents.

“Boxed” instructions like the sample below indicate to the Volume Editor how to integrate the relevant section(s) into the relevant Technical Framework volume.

Replace Section X.X by the following:

Where the amendment adds text, make the added text bold underline. Where the amendment removes text, make the removed text bold strikethrough. When entire new sections are added, introduce with editor’s instructions to “add new text” or similar, which for readability are not bolded or underlined.

General information about IHE can be found at: http://www.ihe.net.

Information about the IHE Pathology and Laboratory Medicine domain can be found at: http://ihe.net/IHE_Domains.

Information about the structure of IHE Technical Frameworks and Supplements can be found at: http://ihe.net/IHE_Process and http://ihe.net/Profiles.

The current version of the IHE Technical Framework (if applicable) can be found at: http://ihe.net/Technical_Frameworks.

Comments may be submitted on IHE Technical Framework templates any time at http://ihe.net/ihetemplates.cfm. Please enter comments/issues as soon as they are found. Do not wait until a future review cycle is announced.

Acknowledgements

Following authors mainly contributed to this document:

  • Francois Macary, PHAST, Paris
  • Dr. Gunter Haroske, Federal Association of German Pathologists, Berlin
  • Dr. Frank Oemig, Deutsche Telekom Healthcare Solutions GmbH, Bonn
  • Dr. Riki Merrick, APHL, San Francisco
  • Dr. Raj Dash, Duke University, Durham

They have to acknowledge the contributions of Dr. Kai U. Heitmann, who managed the cooperation between PaLM and ART-DECOR. It was the very first time that a complete IHE TF document could be developed by means of the ART-DECOR tools and a media wiki.

Introduction to this Supplement

This supplement complements volume 1 of the PaLM technical framework with the description of the APSR 2.0 content profile, and volume 3 with the bindings, content modules and value sets, which specify this profile.

Open Issues and Questions

None yet

Closed Issues

APSR-07 – Representing the hierarchy of specimens in an entry : This APSR supplement enables to represent the hierarchy of specimens at the CDA level 3. The operations on specimen and production of child specimens are tracked in the “Procedure Steps” section, which has a level 3 entry.

APSR-10 – Observation related to multiple specimens: For example tumor staging may require combining data from multiple specimens (e.g., a breast excision with positive margins followed by a re-excision with clear margins – in this case the tumor size may be a composite of measurements from both specimens. Another example is staging of ovarian carcinomas with multiple biopsies of pelvis, peritoneum, nodes, omentum, etc.). To accommodate these use cases, each problem organizer as well as each observation may reference any number of specimens using the <specimen> child element. Each of these references may point to a detailed description of the specimen, in the "procedure steps" section.

APSR-11 – Derivative specimens:Specimens derived from primary specimens for ancillary studies, which may be sent to a reference lab or done in another part of the same institution, are included in the scope of this profile. The results produced on a derived specimen are attached to this specimen in the report.